» Articles » PMID: 12172462

Hemophilia Gene Therapy: Update

Overview
Specialty Hematology
Date 2002 Aug 13
PMID 12172462
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Gene transfer is an exciting and potentially important treatment approach for hemophilia A and B. Four phase I clinical trials of the safety of gene transfer in hemophilia A or B have been completed and two more trials are currently underway. The results of these trials indicate that gene transfer in hemophilia with the vectors and doses used is safe and well tolerated. Efforts continue to understand the basic biology and improve the efficiency of gene transfer.

Citing Articles

Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice.

Shi Q, Carman C, Chen Y, Sage P, Xue F, Liang X Blood Adv. 2020; 4(10):2272-2285.

PMID: 32453842 PMC: 7252558. DOI: 10.1182/bloodadvances.2020001468.


An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

Li B, Luo X, Deng B, Wang J, McComb D, Shi Y Nano Lett. 2015; 15(12):8099-107.

PMID: 26529392 PMC: 4869688. DOI: 10.1021/acs.nanolett.5b03528.


Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Nichols T, Dillow A, Franck H, Merricks E, Raymer R, Bellinger D ILAR J. 2009; 50(2):144-67.

PMID: 19293459 PMC: 3101868. DOI: 10.1093/ilar.50.2.144.


Isolation and therapeutic potential of human haemopoietic stem cells.

Clark A, Jorgensen H, Mountford J, Holyoake T Cytotechnology. 2008; 41(2-3):111-31.

PMID: 19002948 PMC: 3466700. DOI: 10.1023/A:1024822722285.


Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.

Xu L, Nichols T, Sarkar R, McCorquodale S, Bellinger D, Ponder K Proc Natl Acad Sci U S A. 2005; 102(17):6080-5.

PMID: 15837921 PMC: 1087916. DOI: 10.1073/pnas.0409249102.